| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 86851 |
DOTA-octreotide,大环配体奥曲肽 |
133 |
zyl |
2024-11-22 |
| 86852 |
N2-Acetyl-N6-[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-L-lysyl-L-prolyl-N2-methyl-L-arginyl-L-arginyl-L-prolyl-L-tyrosyl-3-methyl-L-valyl-L-leucine |
94 |
wyh |
2024-11-22 |
| 86853 |
DOTA-Ts29.2 DOTA偶联单克隆抗体Ts29.2 |
121 |
zcy |
2024-11-22 |
| 86854 |
DOTA-FAMP α螺旋肽偶联DOTA大环配体 |
114 |
zcy |
2024-11-22 |
| 86855 |
DOTA-NT8-13(靶向NTR1) |
118 |
zcy |
2024-11-22 |
| 86856 |
DOTA Conjugated JM#21 derivative 7 ；3033865-40-3 |
131 |
wyh |
2024-11-22 |
| 86857 |
4-Aminobutyl-DOTA-tris(t-butyl ester) Hexafluorophosphate |
94 |
wyh |
2024-11-22 |
| 86858 |
L-Threonine, N-[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-threonyl-L-cysteinyl-, cyclic (2→7)-disulfide |
92 |
wyh |
2024-11-22 |
| 86859 |
1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid, 1-(2,5-dioxo-1-pyrrolidinyl) ester |
98 |
wyh |
2024-11-22 |
| 86860 |
DOTA-MC1RL 1，4，7，10-四氮杂环十二烷-1，4，7，10-四乙酸缀合MC1R特异性支架 |
131 |
zcy |
2024-11-22 |
| 86861 |
钆布醇杂质20 ；229312-34-9 |
144 |
wyh |
2024-11-22 |
| 86862 |
DOTA-[Nle]-cCCK 科研定制 |
142 |
zcy |
2024-11-22 |
| 86863 |
DOTA-(COOt-Bu)3-CH2-Alkynyl ；1189194-64-6 |
95 |
wyh |
2024-11-22 |
| 86864 |
FITC-PEG2-TATE ；1027160-33-3 |
119 |
wyh |
2024-11-22 |
| 86865 |
DOTA-peg4-LLP2AVLA-4 齐岳定制 |
119 |
zcy |
2024-11-22 |
| 86866 |
蛙皮素肽功能化金纳米颗粒 BBN-AuNPs |
115 |
zcy |
2024-11-22 |
| 86867 |
RGD-DOTA的结构特点 |
120 |
wyh |
2024-11-22 |
| 86868 |
DOTA tris(TBE)-amido-dPEG-bromoacetamide |
102 |
wyh |
2024-11-22 |
| 86869 |
DOTA-PEG-OPSS-AuNP DOTA-PEG-邻吡啶基二硫化物修饰纳米金纳米粒子 |
134 |
zcy |
2024-11-22 |
| 86870 |
DOTA-PEG(23)-MAL*2TFA |
104 |
wyh |
2024-11-22 |
| 86871 |
DOTA偶联PSMA抑制剂 DOTA-PSMA |
115 |
zcy |
2024-11-22 |
| 86872 |
DOTA-PEG(11)-bromoacetamide*2TFA |
118 |
wyh |
2024-11-22 |
| 86873 |
Gn-PAMAM-(TmDOTA(-))(x)(其中n = 1-4，x = 6-39) 齐岳定制 |
127 |
zcy |
2024-11-22 |
| 86874 |
DOTA-(AF)SAv 1，4，7，10-四氮杂环十二烷-N，N′，N″，N″-四乙酸(DOTA)-(AF)SAv |
112 |
zcy |
2024-11-22 |
| 86875 |
PAMAM-DOTA DOTA缀合PAMAM树状大分子 |
153 |
zcy |
2024-11-22 |
| 86876 |
1374865-01-6；10-[2-[[3-(11,12-二脱氢二苯并[B,F]氮杂环辛-5(6H)-基)-3-氧代丙基]氨基]-2-氧代乙基]-1,4,7,10-四氮杂环十二烷-1,4,7-三乙酸 |
126 |
wyh |
2024-11-22 |
| 86877 |
DOTA-(D-Glu)6-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2 齐岳定制 |
130 |
zcy |
2024-11-22 |
| 86878 |
DOTA唑来膦酸盐 ，1908409-18-6 ，DOTA Zoledronate |
122 |
wyh |
2024-11-22 |
| 86879 |
DOTA-C225-AuNPs DOTA修饰西妥昔单抗偶联金纳米颗粒 |
171 |
zcy |
2024-11-22 |
| 86880 |
FAP结合肽大环化合物；2581741-18-4 |
190 |
wyh |
2024-11-22 |
| 86881 |
DOTA-DGlu-Ala-Tyr DOTA偶联受体特异性肽 |
108 |
zcy |
2024-11-22 |
| 86882 |
三（叔丁氧羰基甲基）DOTA氢溴酸盐；137076-54-1 |
116 |
wyh |
2024-11-22 |
| 86883 |
DOTA-h173 双功能螯合剂DOTA偶联h173 |
112 |
zcy |
2024-11-22 |
| 86884 |
DOTA-四聚乙二醇-二苯并环辛炔；DOTA-PEG4-DBCO |
124 |
wyh |
2024-11-22 |
| 86885 |
BSH-3R-DOTA-(64)Cu BSH-3R偶联1，4，7，10-四氮杂环十二烷-1，4，7，10-四乙酸(DOTA) |
123 |
zcy |
2024-11-22 |
| 86886 |
DOTA-三(酸) - 酰氨基-DPEG(R)23-马来酰亚胺 |
135 |
wyh |
2024-11-22 |
| 86887 |
十六烷基-1，4，7，10-四氮杂环十二烷-四乙酸-苯甲酸酯 DOTA-HB |
105 |
zcy |
2024-11-22 |
| 86888 |
DOTA (POL-D)缀合物 |
127 |
zcy |
2024-11-22 |
| 86889 |
DOTA-3-iodo-Tyr3-octreotate DOTA-3-碘-Tyr3-辛酸酯 |
106 |
zcy |
2024-11-22 |
| 86890 |
(177LU)-DOTA-FAPI-04 ；2374782-97-3 |
122 |
wyh |
2024-11-22 |
| 86891 |
DOTA-NT20.3 1, 4, 7, 10-四氮杂环十二烷-1, 4, 7, 10-四乙酸-NT-20.3 |
108 |
zcy |
2024-11-22 |
| 86892 |
DOTA-去乙酰秋水仙碱(68Ga-1) |
107 |
zcy |
2024-11-22 |
| 86893 |
DOTA-[NaI(3)]-奥曲肽 DOTA-NOC |
118 |
zcy |
2024-11-22 |
| 86894 |
大环螯合剂1，4，7，10-四氮杂环十二烷N,N',N″,N‴-tetra乙酸(DOTA)偶联n-α-(9-芴基甲氧基羰基)-l-赖氨酸 |
109 |
zcy |
2024-11-22 |
| 86895 |
nDOTA-Mal 1，4，7，10-四氮杂环十二烷- 1，4，7-三乙酸-10-马来酰亚胺基乙基乙酰胺 |
107 |
zcy |
2024-11-22 |
齐岳微信公众号
官方微信
库存查询